Click Here to
News, Updates,
& More
Stay Up
to Date

Health Policy

FDA Commissioner Scott Gottlieb, MD, announced new steps as part of the FDA’s Drug Competition Action Plan to promote generic drug competition as a way to expand potential access to inexpensive medicines, which would be especially helpful for patients with cancer.

Results 1 - 1 of 1